Elevated serum creatine phosphokinase in subjects with McLeod syndrome.
McLeod phenotype red cells of the Kell blood group system have acanthocytic morphology and reduced in vivo survival. The phenotype has an X-linked mode of inheritance and is found in some males who have no abnormality of leukocyte function and in some who have X-linked chronic granulomatous disease (CGD). We now describe an association between the McLeod phenotype and an abnormal elevation of serum creatine phosphokinase (CPK). The increase is of the MM isoenzyme type, derived from skeletal muscle or cardiac muscle, and muscle biopsy shows evidence of muscle cell changes. All of 11 males who have McLeod syndrome but do not have CGD have high levels of serum CPK. Males with McLeod syndrome and CGD may have normal or high levels of the enzyme. Individuals with other variant phenotypes in the Kell system have normal levels of serum CPK. Studies on a large kindred, which includes 5 people of McLeod phenotype, show high CPK levels only in the members of McLeod type. We conclude that the high level of CPK in the serum of these people is a reflection of a muscle cell anomaly and that in these individuals it is a pleiotropic effect of the X-linked gene that produces the McLeod red cell phenotype.
D000745:Anemia, Hemolytic, Congenital / Q000097:blood / Q000235:genetics* / Q000473:pathology; D001789:Blood Group Antigens / Q000235:genetics*; D003402:Creatine Kinase / Q000097:blood*; D005260:Female; D006801:Humans; D007626:Kell Blood-Group System / Q000235:genetics*; D008297:Male; D009132:Muscles / Q000473:pathology; D010375:Pedigree; D010641:Phenotype; D012729:Sex Chromosome Aberrations / Q000097:blood / Q000235:genetics / Q000473:pathology; D013577:Syndrome; D014960:X Chromosome
D001789:Blood Group Antigens; D007626:Kell Blood-Group System; D003402:Creatine Kinase